We are live on ! Find out more
ACM

Azimuth Capital Management Portfolio holdings

AUM $2.34B
1-Year Est. Return 16.67%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+16.67%
3 Year Est. Return
+80.26%
5 Year Est. Return
+136.66%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$315M
Cap. Flow
+$86.9M
Cap. Flow %
4.31%
Top 10 Hldgs %
16.53%
Holding
307
New
37
Increased
120
Reduced
112
Closed
7

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$11M
2
EW icon
Edwards Lifesciences
EW
+$6.46M
3
ACN icon
Accenture
ACN
+$6.34M
4
NVDA icon
NVIDIA
NVDA
+$6.17M
5
V icon
Visa
V
+$4.32M

Sector Composition

Rank Sector Weight
1 Technology 23.29%
2 Healthcare 18.51%
3 Consumer Staples 9.98%
4 Financials 9.86%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
26
PayPal
PYPL
$48.9B
$19.5M 0.97%
83,118
+721
+0.9% +$149K
UNH icon
27
UnitedHealth
UNH
$376B
$19.5M 0.97%
55,478
+103
+0.2% +$34.5K
APH icon
28
Amphenol
APH
$198B
$19M 0.94%
580,992
+163,040
+39% +$5.01M
COST icon
29
Costco
COST
$422B
$18.3M 0.91%
48,455
+45
+0.1% +$16.8K
IDXX icon
30
Idexx Laboratories
IDXX
$44.1B
$18.1M 0.9%
36,151
-655
-2% -$293K
NOW icon
31
ServiceNow
NOW
$115B
$17.7M 0.88%
160,520
+425
+0.3% +$44.2K
ISRG icon
32
Intuitive Surgical
ISRG
$127B
$16.9M 0.84%
62,106
+525
+0.9% +$130K
SBUX icon
33
Starbucks
SBUX
$120B
$16.8M 0.83%
156,950
+571
+0.4% +$54.5K
NKE icon
34
Nike
NKE
$61.9B
$16.4M 0.81%
116,067
+1,420
+1% +$188K
RMD icon
35
ResMed
RMD
$30.6B
$16M 0.79%
75,214
-1,425
-2% -$284K
INTC icon
36
Intel
INTC
$455B
$15.9M 0.79%
319,850
+44,445
+16% +$2.17M
V icon
37
Visa
V
$684B
$15.6M 0.78%
71,447
-21,131
-23% -$4.32M
EPAM icon
38
EPAM Systems
EPAM
$5.51B
$15.4M 0.77%
43,076
+1,293
+3% +$432K
WDAY icon
39
Workday
WDAY
$39.6B
$15.2M 0.75%
63,336
+32,535
+106% +$7.31M
MRK icon
40
Merck
MRK
$322B
$15.1M 0.75%
193,945
-1,153
-0.6% -$88.2K
EL icon
41
Estee Lauder
EL
$30.4B
$14.7M 0.73%
55,055
+462
+0.8% +$111K
ZTS icon
42
Zoetis
ZTS
$32.4B
$14.4M 0.71%
86,734
+1,963
+2% +$319K
ACN icon
43
Accenture
ACN
$102B
$14.3M 0.71%
54,701
-26,441
-33% -$6.34M
FAST icon
44
Fastenal
FAST
$54.7B
$13.7M 0.68%
560,960
-5,010
-0.9% -$118K
WST icon
45
West Pharmaceutical
WST
$24B
$13.4M 0.67%
47,406
+443
+0.9% +$124K
PG icon
46
Procter & Gamble
PG
$336B
$13.4M 0.67%
96,489
-1,158
-1% -$162K
CMCSA icon
47
Comcast
CMCSA
$85B
$13.3M 0.66%
252,920
+6,742
+3% +$323K
MDLZ icon
48
Mondelez International
MDLZ
$79.5B
$13M 0.64%
221,993
-5,330
-2% -$305K
ROST icon
49
Ross Stores
ROST
$80.5B
$12.8M 0.64%
104,593
+50,171
+92% +$5.26M
VZ icon
50
Verizon
VZ
$195B
$12.8M 0.64%
218,486
+6,751
+3% +$401K

Similar funds

Azimuth Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Azimuth Capital Management held 307 positions worth $2.02B, up 19% from $1.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Azimuth Capital Management deployed $86.9M of net new capital in Q4 2020, opening 37 new positions and adding to 120 existing holdings. Its largest new stake was iShares iBonds Dec 2026 Term Muni Bond ETF: 384,200 shares worth $10.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $6.46M trimmed.

  • Azimuth Capital Management's largest Q4 2020 buy was iShares iBonds Dec 2026 Term Muni Bond ETF: 384,200 shares worth $10.4M.
  • Azimuth Capital Management added most to Discover Financial Services in Q4 2020, an estimated $13.2M increase.
  • Azimuth Capital Management's biggest Q4 2020 reduction was Edwards Lifesciences, cutting an estimated $6.46M.
  • Azimuth Capital Management fully exited SAP in Q4 2020, selling an estimated $11M.
  • Azimuth Capital Management's ten largest holdings make up 17% of its $2.02B portfolio in Q4 2020.
  • Azimuth Capital Management opened 37 new positions and closed 7 in Q4 2020.
  • Azimuth Capital Management's portfolio value rose 19% quarter-over-quarter to $2.02B.

Based on Azimuth Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.